InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: None

Sunday, 05/03/2015 6:59:35 PM

Sunday, May 03, 2015 6:59:35 PM

Post# of 80868
Musclepharm misrepresents revenue guidance by pumping up high expectations when it got sufficient partial information and remains silent when it got perfect information.

Close to the end of Q1, Brad and Co. remained completely silent with close to complete knowledge of quarter's sales. This is what is referred to as "misrepresentation by silence" in common law.

Mid Q4, Brad and Co. had no problems giving guidance.